Brooklyn Immunotherapeutics Inc Annual Shareholders Meeting Transcript
Good day, and welcome to the Brooklyn ImmunoTherapeutics Annual Meeting of Stockholders. I would now like to turn the conference over to Matt Angel, Interim CEO. Please, go ahead.
Good morning, ladies and gentlemen. I am Matt Angel, and I am the Interim Chief Executive Officer and a director of Brooklyn ImmunoTherapeutics, Inc. It is a pleasure to welcome you to our 2022 Annual Meeting of Stockholders.
We are holding a virtual annual meeting of stockholders, which means the annual meeting takes place exclusively via Internet webcast. Stockholders attending the virtual meeting via Internet webcast may vote their shares online in real time until the polls are closed. The polls to vote online are currently open. If you have already submitted a proxy to vote your shares, you do not need to submit an online ballot, unless you want to change your vote.
We have asked Andrew Jackson, our Chief Financial Officer and Corporate Secretary, to record the minutes of this meeting; and Jim Alden of American
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |